Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Kunsheng Capital is a specialized investment firm based in China that focuses exclusively on the healthcare and life sciences sectors. The firm manages various investment vehicles, including the Kunsheng Relay Fund, which is designed to support growth-stage companies in the biotechnology, medical device, and diagnostic industries. Kunsheng Capital provides not only financial backing but also strategic resources to help its portfolio companies navigate the complex regulatory and commercial landscape in China. Their investment strategy emphasizes innovation and clinical value, targeting companies that address significant unmet medical needs. The firm has established itself as a significant participant in the Chinese venture capital ecosystem through successful investments in several leading biotech enterprises.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Kunsheng Relay Fund.